# Ralph Lauren Corp: financial statements, quarterly RL · NYSE · CIK 1037038 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 28 Pages: [Overview](/companies/rl.md) · [Financials](/companies/rl/financials.md) · [Filings](/companies/rl/filings.md) · [Insiders](/companies/rl/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rl/financials.md?period=annual). ## Income statement | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-30) | Q4 FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q4 FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | Q4 FY2026 (2026-03-28) | Q1 FY2027 (2026-06-27) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1,633](/filings/0001037038-24-000029.md) | [1,934](/filings/0001037038-25-000007.md) | [1,568 d](/filings/0001628280-26-037074.md) | [1,512](/filings/0001037038-25-000018.md) | [1,726](/filings/0001628280-25-049927.md) | [2,144](/filings/0001628280-26-005784.md) | [1,697 d](/filings/0001628280-26-037074.md) | [1,719](/filings/0001628280-26-053992.md) | [2,011](/filings/0001628280-25-049927.md) | [2,406](/filings/0001628280-26-005784.md) | [1,979 d](/filings/0001628280-26-037074.md) | [1,960](/filings/0001628280-26-053992.md) | | Cost of revenue | $m | [563](/filings/0001037038-24-000029.md) | [648](/filings/0001037038-25-000007.md) | [524 d](/filings/0001628280-26-037074.md) | [446](/filings/0001037038-25-000018.md) | [570](/filings/0001628280-25-049927.md) | [677](/filings/0001628280-26-005784.md) | [532 d](/filings/0001628280-26-037074.md) | [477](/filings/0001628280-26-053992.md) | [644](/filings/0001628280-25-049927.md) | [724](/filings/0001628280-26-005784.md) | [600 d](/filings/0001628280-26-037074.md) | [516](/filings/0001628280-26-053992.md) | | Gross profit | $m | [1,070](/filings/0001037038-24-000029.md) | [1,286](/filings/0001037038-25-000007.md) | [1,044 d](/filings/0001628280-26-037074.md) | [1,066](/filings/0001037038-25-000018.md) | [1,156](/filings/0001628280-25-049927.md) | [1,466](/filings/0001628280-26-005784.md) | [1,165 d](/filings/0001628280-26-037074.md) | [1,242](/filings/0001628280-26-053992.md) | [1,366](/filings/0001628280-25-049927.md) | [1,682](/filings/0001628280-26-005784.md) | [1,379 d](/filings/0001628280-26-037074.md) | [1,444](/filings/0001628280-26-053992.md) | | Selling, general and administrative | $m | [896](/filings/0001037038-24-000029.md) | [968](/filings/0001037038-25-000007.md) | [907 d](/filings/0001628280-26-037074.md) | [850](/filings/0001037038-25-000018.md) | [958](/filings/0001628280-25-049927.md) | [1,064](/filings/0001628280-26-005784.md) | [991 d](/filings/0001628280-26-037074.md) | [949](/filings/0001628280-26-053992.md) | [1,083](/filings/0001628280-25-049927.md) | [1,179](/filings/0001628280-26-005784.md) | [1,161 d](/filings/0001628280-26-037074.md) | [1,077](/filings/0001628280-26-053992.md) | | Operating income | $m | [165](/filings/0001037038-24-000029.md) | [318](/filings/0001037038-25-000007.md) | [108 d](/filings/0001628280-26-037074.md) | [209](/filings/0001037038-25-000018.md) | [179](/filings/0001628280-25-049927.md) | [390](/filings/0001628280-26-005784.md) | [155 d](/filings/0001628280-26-037074.md) | [274](/filings/0001628280-26-053992.md) | [246](/filings/0001628280-25-049927.md) | [471](/filings/0001628280-26-005784.md) | [189 d](/filings/0001628280-26-037074.md) | [342](/filings/0001628280-26-053992.md) | | Interest expense | $m | [10.0](/filings/0001037038-24-000029.md) | [10.6](/filings/0001037038-25-000007.md) | [11.6 d](/filings/0001628280-26-037074.md) | [10.9](/filings/0001037038-25-000018.md) | [11.4](/filings/0001628280-25-049927.md) | [11.6](/filings/0001628280-26-005784.md) | [10.2 d](/filings/0001628280-26-037074.md) | [11.5](/filings/0001628280-26-053992.md) | [15.9](/filings/0001628280-25-049927.md) | [13.3](/filings/0001628280-26-005784.md) | [13.5 d](/filings/0001628280-26-037074.md) | [13.0](/filings/0001628280-26-053992.md) | | Income tax | $m | [18.6](/filings/0001037038-24-000029.md) | [53.2](/filings/0001037038-25-000007.md) | [20.8 d](/filings/0001628280-26-037074.md) | [48.0](/filings/0001037038-25-000018.md) | [40.2](/filings/0001628280-25-049927.md) | [86.3](/filings/0001628280-26-005784.md) | [33.3 d](/filings/0001628280-26-037074.md) | [57.6](/filings/0001628280-26-053992.md) | [35.3](/filings/0001628280-25-049927.md) | [102](/filings/0001628280-26-005784.md) | [41.5 d](/filings/0001628280-26-037074.md) | [80.0](/filings/0001628280-26-053992.md) | | Net income | $m | [147](/filings/0001037038-24-000029.md) | [277](/filings/0001037038-25-000007.md) | [90.7 d](/filings/0001628280-26-037074.md) | [169](/filings/0001037038-25-000018.md) | [148](/filings/0001628280-25-049927.md) | [297](/filings/0001628280-26-005784.md) | [129 d](/filings/0001628280-26-037074.md) | [220](/filings/0001628280-26-053992.md) | [208](/filings/0001628280-25-049927.md) | [362](/filings/0001628280-26-005784.md) | [152 d](/filings/0001628280-26-037074.md) | [262](/filings/0001628280-26-053992.md) | | Diluted EPS | $ per share | [2.19](/filings/0001037038-24-000029.md) | [4.19](/filings/0001037038-25-000007.md) | not reported | [2.61](/filings/0001037038-25-000018.md) | [2.31](/filings/0001628280-25-049927.md) | [4.66](/filings/0001628280-26-005784.md) | not reported | [3.52](/filings/0001628280-26-053992.md) | [3.32](/filings/0001628280-25-049927.md) | [5.82](/filings/0001628280-26-005784.md) | not reported | [4.28](/filings/0001628280-26-053992.md) | | Basic EPS | $ per share | [2.24](/filings/0001037038-24-000029.md) | [4.25](/filings/0001037038-25-000007.md) | not reported | [2.67](/filings/0001037038-25-000018.md) | [2.36](/filings/0001628280-25-049927.md) | [4.76](/filings/0001628280-26-005784.md) | not reported | [3.62](/filings/0001628280-26-053992.md) | [3.39](/filings/0001628280-25-049927.md) | [5.91](/filings/0001628280-26-005784.md) | not reported | [4.36](/filings/0001628280-26-053992.md) | - Revenue: us-gaap:Revenues - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-30) | FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | FY2026 (2026-03-28) | Q1 FY2027 (2026-06-27) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [1,382](/filings/0001037038-23-000030.md) | [1,804](/filings/0001037038-24-000008.md) | [1,662](/filings/0001037038-25-000011.md) | [1,587](/filings/0001037038-24-000022.md) | [1,355](/filings/0001037038-24-000029.md) | [1,940](/filings/0001037038-25-000007.md) | [1,923](/filings/0001628280-26-037074.md) | [2,090](/filings/0001037038-25-000018.md) | [1,443](/filings/0001628280-25-049927.md) | [2,032](/filings/0001628280-26-005784.md) | [1,988](/filings/0001628280-26-053992.md) | [1,719](/filings/0001628280-26-053992.md) | | Current assets | $m | [3,395](/filings/0001037038-23-000030.md) | [3,639](/filings/0001037038-24-000008.md) | [3,360](/filings/0001037038-25-000011.md) | [3,448](/filings/0001037038-24-000022.md) | [3,605](/filings/0001037038-24-000029.md) | [3,900](/filings/0001037038-25-000007.md) | [3,790](/filings/0001628280-26-037074.md) | [4,199](/filings/0001037038-25-000018.md) | [3,753](/filings/0001628280-25-049927.md) | [4,189](/filings/0001628280-26-005784.md) | [3,887](/filings/0001628280-26-053992.md) | [3,835](/filings/0001628280-26-053992.md) | | Total assets | $m | [6,723](/filings/0001037038-23-000030.md) | [7,005](/filings/0001037038-24-000008.md) | [6,603](/filings/0001037038-25-000011.md) | [6,641](/filings/0001037038-24-000022.md) | [6,800](/filings/0001037038-24-000029.md) | [7,081](/filings/0001037038-25-000007.md) | [7,047](/filings/0001628280-26-037074.md) | [7,752](/filings/0001037038-25-000018.md) | [7,348](/filings/0001628280-25-049927.md) | [7,814](/filings/0001628280-26-005784.md) | [7,740](/filings/0001628280-26-053992.md) | [7,659](/filings/0001628280-26-053992.md) | | Current liabilities | $m | [1,610](/filings/0001037038-23-000030.md) | [1,678](/filings/0001037038-24-000008.md) | [1,467](/filings/0001037038-25-000011.md) | [1,574](/filings/0001037038-24-000022.md) | [2,092](/filings/0001037038-24-000029.md) | [2,222](/filings/0001037038-25-000007.md) | [2,134](/filings/0001628280-26-037074.md) | [2,286](/filings/0001037038-25-000018.md) | [1,840](/filings/0001628280-25-049927.md) | [1,996](/filings/0001628280-26-005784.md) | [1,827](/filings/0001628280-26-053992.md) | [1,876](/filings/0001628280-26-053992.md) | | Total liabilities | $m | [4,354](/filings/0001037038-23-000030.md) | [4,433](/filings/0001037038-24-000008.md) | [4,152](/filings/0001037038-25-000011.md) | [4,274](/filings/0001037038-24-000022.md) | [4,358](/filings/0001037038-24-000029.md) | [4,542](/filings/0001037038-25-000007.md) | [4,459](/filings/0001628280-26-037074.md) | [5,236](/filings/0001037038-25-000018.md) | [4,766](/filings/0001628280-25-049927.md) | [4,925](/filings/0001628280-26-005784.md) | [4,898](/filings/0001628280-26-053992.md) | [4,937](/filings/0001628280-26-053992.md) | | Long-term debt | $m | [1,140](/filings/0001037038-23-000030.md) | [1,140](/filings/0001037038-24-000008.md) | [1,141](/filings/0001037038-25-000011.md) | [1,141](/filings/0001037038-24-000022.md) | [742](/filings/0001037038-24-000029.md) | [743](/filings/0001037038-25-000007.md) | [743](/filings/0001628280-26-037074.md) | [1,237](/filings/0001037038-25-000018.md) | [1,238](/filings/0001628280-25-049927.md) | [1,238](/filings/0001628280-26-005784.md) | [1,239](/filings/0001628280-26-053992.md) | [1,239](/filings/0001628280-26-053992.md) | | Current portion of debt | $m | not reported | not reported | [0.0](/filings/0001037038-25-000011.md) | not reported | [399](/filings/0001037038-24-000029.md) | [400](/filings/0001037038-25-000007.md) | [400](/filings/0001628280-26-037074.md) | [400](/filings/0001037038-25-000018.md) | [0.0](/filings/0001628280-25-049927.md) | [0.0](/filings/0001628280-26-005784.md) | [0.0](/filings/0001628280-26-037074.md) | not reported | | Short-term borrowings | $m | [0.0](/filings/0001037038-23-000030.md) | [0.0](/filings/0001037038-24-000008.md) | [0.0](/filings/0001037038-25-000011.md) | [0.0](/filings/0001037038-24-000022.md) | [0.0](/filings/0001037038-24-000029.md) | [0.0](/filings/0001037038-25-000007.md) | [0.0](/filings/0001628280-26-037074.md) | [0.0](/filings/0001037038-25-000018.md) | [0.0](/filings/0001628280-25-049927.md) | [0.0](/filings/0001628280-26-005784.md) | [0.0](/filings/0001628280-26-053992.md) | [0.0](/filings/0001628280-26-053992.md) | | Shareholders' equity | $m | [2,369](/filings/0001037038-25-000007.md) | [2,572](/filings/0001037038-25-000007.md) | [2,450](/filings/0001628280-26-037074.md) | [2,367](/filings/0001628280-25-049927.md) | [2,442](/filings/0001628280-26-005784.md) | [2,539](/filings/0001628280-26-005784.md) | [2,589](/filings/0001628280-26-053992.md) | [2,515](/filings/0001628280-26-053992.md) | [2,582](/filings/0001628280-26-005784.md) | [2,888](/filings/0001628280-26-005784.md) | [2,841](/filings/0001628280-26-053992.md) | [2,722](/filings/0001628280-26-053992.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Short-term borrowings: us-gaap:CommercialPaper - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-30) | Q4 FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q4 FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | Q4 FY2026 (2026-03-28) | Q1 FY2027 (2026-06-27) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [72.9 d](/filings/0001037038-24-000029.md) | [605 d](/filings/0001037038-25-000007.md) | [121 d](/filings/0001628280-26-037074.md) | [277](/filings/0001037038-25-000018.md) | [97.2 d](/filings/0001628280-25-049927.md) | [738 d](/filings/0001628280-26-005784.md) | [122 d](/filings/0001628280-26-037074.md) | [176](/filings/0001628280-26-053992.md) | [53.2 d](/filings/0001628280-25-049927.md) | [780 d](/filings/0001628280-26-005784.md) | [145 d](/filings/0001628280-26-037074.md) | [339](/filings/0001628280-26-053992.md) | | Capital expenditure | $m | [42.8 d](/filings/0001037038-24-000029.md) | [42.5 d](/filings/0001037038-25-000007.md) | [39.9 d](/filings/0001037038-25-000011.md) | [33.4](/filings/0001037038-25-000018.md) | [41.7](/filings/0001628280-25-049927.md) | [61.2](/filings/0001628280-26-005784.md) | [79.9 d](/filings/0001037038-25-000011.md) | [187](/filings/0001628280-26-053992.md) | [93.8](/filings/0001628280-25-049927.md) | [75.6](/filings/0001628280-26-005784.md) | not reported | [53.4](/filings/0001628280-26-053992.md) | | Dividends paid | $m | [49.0 d](/filings/0001037038-24-000029.md) | [48.5 d](/filings/0001037038-25-000007.md) | [47.9 d](/filings/0001628280-26-037074.md) | [47.5](/filings/0001037038-25-000018.md) | [51.4 d](/filings/0001628280-25-049927.md) | [51.2 d](/filings/0001628280-26-005784.md) | [51.0 d](/filings/0001628280-26-037074.md) | [50.7](/filings/0001628280-26-053992.md) | [55.3 d](/filings/0001628280-25-049927.md) | [55.3 d](/filings/0001628280-26-005784.md) | [55.2 d](/filings/0001628280-26-037074.md) | [54.8](/filings/0001628280-26-053992.md) | | Share repurchases | $m | [169 d](/filings/0001037038-24-000029.md) | [103 d](/filings/0001037038-25-000007.md) | [121 d](/filings/0001628280-26-037074.md) | [201](/filings/0001037038-25-000018.md) | [129 d](/filings/0001628280-25-049927.md) | [74.4 d](/filings/0001628280-26-005784.md) | [76.3 d](/filings/0001628280-26-037074.md) | [323](/filings/0001628280-26-053992.md) | [113 d](/filings/0001628280-25-049927.md) | [37.5 d](/filings/0001628280-26-005784.md) | [150 d](/filings/0001628280-26-037074.md) | [325](/filings/0001628280-26-053992.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q2 FY2023 (2022-10-01) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-07-01) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | Q1 FY2027 (2026-06-27) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [69.0](/filings/0001037038-23-000030.md) | [67.6](/filings/0001037038-24-000008.md) | [67.4](/filings/0001037038-24-000022.md) | [67.2](/filings/0001037038-24-000029.md) | [66.0](/filings/0001037038-25-000007.md) | [64.6](/filings/0001037038-25-000018.md) | [63.9](/filings/0001628280-25-049927.md) | [63.8](/filings/0001628280-26-005784.md) | [62.5](/filings/0001628280-26-053992.md) | [62.4](/filings/0001628280-25-049927.md) | [62.2](/filings/0001628280-26-005784.md) | [61.3](/filings/0001628280-26-053992.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.